col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


123 Results       Page 1

 [1] 
SPb RAACI: Russian Journal of Infection and Immunity
  original article Date Title Authors   All Authors
1 [GO] 2024―Dec―09 ARVI PATTERN IN THE NORTHWEST FEDERAL DISTRICT DURING THE COVID-19 PANDEMIC (2021-2022) V A Sbarzaglia, A S Gladkikh, D M Milichkina, A V Bachevskaya, М R Popova, E A Cherepanova, et al. (+2)
2 [GO] 2024―Dec―09 EPIDEMIOLOGICAL TRENDS IN ALGERIAN WILAYAS DURING THE COVID-19 PANDEMIC Zineb HARFOUCHE, Amine AMIMOUR
3 [GO] 2024―Dec―09 ARE HIV-INFECTED PEOPLE AT RISK GROUP FOR COVID-19 MORBIDITY AND SEVERE COURSE? Victor I. Sergevnin, Marina Vladimirovna Rozhkova, Rashid Gabbasovich Gibadulin
4 [GO] 2024―Dec―09 A RELATION BETWEEN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSwNP) AND COVID-19 COURSE Elena Lyubimova, Elena Savlevich, Alexander Zurochka, Elizaveta Mitrofanova
5 [GO] 2024―Dec―09 IMMUNOGENETIC MARKERS OF COVID-19 SEVERITY IN ST. PETERSBURG RESIDENTS Elena Vital’evna Kuzmich, Irina Evgenievna Pavlova, Tatyana Valentinovna Glazanova, Elena Romanovna Shilova, Ludmila Nikolaevna Bubnova
6 [GO] 2024―Dec―09 ASSESSMENT OF INFLUENZA AND COVID-19 VACCINE EPIDEMIOLOGIC EFFICACY IN THE 2020-2021, 2021-2022, 2022-2023 SEASONS IN NOVOSIBIRSK Tereza A. Saroyan, Olga G. Kurskaya, Maria Vladimirovna Solomatina, Kirill Alexandrovich Sharshov, Аlexandr M. Shestopalov, Mariana K. Erofeeva, et al. (+3)
7 [GO] 2024―Dec―09 ROLE OF TOLL-LIKE RECEPTOR POLYMORPHISMS IN THE DEVELOPMENT OF EXTREMELY SEVERE COVID-19 WITH FATAL OUTCOME Ludmila Ashchina, Nadezhda Ivanovna Baranova, Oksana Alexandrovna Kulieva, Alexandra Igorevna Bolgova
8 [GO] 2024―Dec―09 EXPERIENCE OF USING THE PREPARATION GLUCAFERON WITHIN A COMBINATION THERAPY OF MODERATE SARS-COV-2-CAUSED NOVEL CORONAVIRUS INFECTION Nikita O. Shatyy, Evgeniya V. Bezrukova, Valentina G. Konusova, Evgeniy V. Vorobeychikov, Sergey A. Artyshkin, Andrey S. Simbircev
9 [GO] 2024―Dec―09 SAFETY AND SPECIFIC ACTIVITY OF THE RECOMBINANT SARS-COV-2 (CORONADERM-PS) ALLERGEN BASED ON PHASE I-II CLINICAL TRIAL RESULTS Tikhon V. Savin, Angelica M. Milichkina, Alexey A. Krasnov, Raisa N. Kuznetsova, Elena E. Shchederkina, Alena V. Svarval, et al. (+15)
10 [GO] 2024―Dec―09 THE IMPACT OF CONCOMITANT DISEASES DURING SARS-COV-2 INFECTION IN RESIDENTS OF KAZAKHSTAN Mayra Zangarovna Ashirova, Gulzhan Narkenovna Abuova, Bibigul Toelegenovna Seytkhanova
11 [GO] 2024―Dec―09 ANTIGENIC FEATURES OF THE STRAINS SARS-COV-2 OF OMICRON SUBLINES ASSESSED BY HYPERIMMUNE MOUSE SERUM NEUTRALISATION Anna Vladimirovna Zaykovskaya, Vasily Aleksandrovich Evseenko, Sergey Evgenievich Olkin, Oleg Victorovich Pyankov
12 [GO] 2024―Dec―09 GENOMIC DIVERSITY OF TOXIGENIC VIBRIO CHOLERAE O1 BIOVAR EL TOR STRAINS ISOLATED DURING THREE WAVES OF THE 7TH CHOLERA PANDEMIC Nina Ivanovna Smirnova, Darya Alexandrovna Rybal’chenko, Yulii Vladislavovich Lozovskiy, Yaroslav Mikhailovich Krasnov, Elena Yur'evna Schelkanova, Andrej Vital'evich Fedorov, Vladimir Viktorovich Kutyrev
13 [GO] 2024―Oct―30 New promising antiseptics for individual antiviral protection against seasonal infections including COVID-19 S. A. Lepekhova, G. E. Grigor’ev, Ilya S. Kurganskiy
14 [GO] 2024―Oct―30 Post-vaccination immunity and pneumonia incidence in medical workers in response to various flu vaccination regimens between the 1st and 2nd peaks of COVID-19 morbidity Mikhail Petrovich Kostinov, N. Yu. Nastaeva, N. F. Nikityuk, K. V. Mashilov, A. A. Khasanova, I. L. Solovyeva, et al. (+7)
15 [GO] 2024―Oct―30 Altered leukocyte blood count in COVID-19 pandemic period Sergey N. Kostarev, T. G. Sereda
16 [GO] 2024―Oct―30 The effect of a new coronavirus infection on hemogram parameters in the early convalescence period of patients with coronary heart disease Nikolay M. Agarkov, T. I. Yakunchenko, O. I. Okhotnikov, K. F. Makkonen, M. V. Alymova
17 [GO] 2024―Aug―05 Dental and microbiological status of COVID-19 convalescent patients with simple marginal gingivitis A. V. Lyamin, A. V. Vinnik, M. A. Postnikov, S. V. Vinnik, N. V. Popov, D. V. Alekseev
18 [GO] 2024―Aug―05 Assessing molecular genetic and immunological predictors of COVID-19 course in healthcare worker risk group I. D. Reshetnikova, Yu. A. Tyurin, I. G. Mustafin, E. V. Agafonova, N. D. Shaуkhrazieva
19 [GO] 2024―Aug―05 Features of T-cell and humoral immunity of patients with acute coronary syndrome, with and without COVID-19, depending on/peripheral blood B-lymphocytes with the phenotype CD3-CD19+CD5+ level E. A. Safronova, L. V. Ryabova, Александр Vladimirovich Zurochka, M. А. Dobrynina
20 [GO] 2024―Aug―05 The association between the history of supplement use (vitamin or mineral) and COVID-19 disease in the persian cohort population F. Ghorat, A. Ganj Bakhsh, R. Ataee, R. Borghabani, Z. Jalambadani
21 [GO] 2024―Aug―05 Forecasting infection fatality rate of COVID-19: measuring the efficiency of several hybrid models D. Seba, K. Belaide
22 [GO] 2024―Aug―05 Autoimmune disorders in patients with granulomatosis diseases after COVID-19: T- and B-cells subsets function A. A. Starshinova, I. V. Kudryavtsev, A. A. Rubinstein, A. Malkova, H. Ling, M. Zhuang, et al. (+3)
23 [GO] 2024―Aug―05 Immune status of patients with community-acquired pneumonia associated with a new coronavirus infection and other viral and bacterial pathogens I. A. Ivanova, A. V. Filippenko, N. V. Pavlovich, N. V. Aronova, M. V. Tsimbalistova, A. S. Anisimova, et al. (+4)
24 [GO] 2024―Aug―05 Coronavirus spike protein fragment-containing chimeric virus-like particles stimulate human dendritic cell maturation V. Yu. Talayev, D. V. Novikov, I. Ye. Zaichenko, M. V. Svetlova, E. V. Voronina, O. N. Babaykina, et al. (+5)
25 [GO] 2024―Aug―05 Experimentally investigated “CoronaDerm-PS”-driven SARS-CoV-2-specific cellular immunity and safety T. V. Savin, V. V. Kopat, A. A. Riabchenkova, E. L. Chirak, E. R. Chirak, A. I. Saenko, et al. (+8)
26 [GO] 2024―Jul―28 Algorithm for assessing the level of T cell immune response against SARS-CoV-2 and the results of its application in unvaccinated and vaccinated people who have been infected with COVID-19 M. S. Blyakher, Irina M. Fedorova, S. I. Koteleva, I. V. Kapustin, E. A. Tulskaya, Z. K. Ramazanova, et al. (+4)
27 [GO] 2024―Jul―28 Comparative assessment of interferon activity in influenza and COVID-19 Tatiana P. Ospelnikova, O. A. Svitich, F. I. Ershov
28 [GO] 2024―Jul―28 IL-6 and IL-18 cytokine traps in COVID-19 A. A. Korotaeva, Elena V. Samoilova, D. A. Chepurnova, N. V. Pogosova, D. T. Kuchiev, F. N. Paleev
29 [GO] 2024―Jul―28 Laboratory blood markers in COVID-19 and their connection to Viral variant Zoya R. Korobova, N. E. Liubimova, N. A. Arsentieva, M. S. Zhebeleva, E. I. Chernykh, V. V. Davletshina, et al. (+2)
30 [GO] 2024―Jul―28 Expression of pro-inflammatory cytokines (IL-18, IL-33) at the level of the mucous membrane, the entry point of infection, in persons who have experienced COVID-19 disease Nadezhda D. Rasskazova, N. D. Abramova, T. D. Soshchenko, N. O. Kalyuzhnaya, E. A. Meremianina, M. N. Shatokhin, T. A. Zaitseva
31 [GO] 2024―Jul―28 Balance of pro- and anti-inflammatory cytokines in young patients who passed active Immunization against SARS-CoV-2 during the COVID-19 Pandemic Yulia A. Li, M. N. Dmitrachenko, E. V. Markelova, I. B. Korolev, M. P. Kostinov, L. I. Bondar
32 [GO] 2024―Jul―28 Characteristics of virus-specific immunological reactions following COVID-19 vaccination in heart transplant recipients Marina M. Zafranskaya, D. B. Nizheharodava, O. G. Shatova, I. I. Russkih, A. V. Velichko, M. I. Vanslau, et al. (+4)
33 [GO] 2024―Jul―28 Broncho-obstructive syndrome and the enzymes of cellular energy metabolism after coronavirus infection Ninel I. Kosyakova, M. V. Akulenko
34 [GO] 2024―Jul―28 Blood cytokines as potential predictors of the development of SARS-CoV-2 associated pneumonia in patients with stage II ESSENTIAL hypertension Olga A. Radaeva, A. S. Simbirtsev, M. S. Iskandyarova, E. V. Negodnova, V. V. Kulyapkin, K. A. Krasnoglazova, V. V. Eremeev
35 [GO] 2024―Jul―28 Plasmablast response during acute SARS-CoV-2 infection Maria G. Byazrova, M. M. Sukhova, A. A. Mikhailov, A. F. Romanova, G. M. Yusubaliyeva, A. V. Filatov
36 [GO] 2024―Apr―28 Differences in complete blood count parameters in patients with COVID-19 diagnosis based on vaccination status (literature review) A. V. Konyuhov, A. M. Kostinova, M. N. Loktionova, M. P. Kostinov, A. S. Pechenik
37 [GO] 2024―Apr―28 Comparatively analyzed pattern of Delta and Omicron SARS-CoV-2 genovariant dominated COVID-19 incidence in the population of the Saratov region A. A. Zimirova, V. E. Kuklev, V. A. Safronov, I. N. Vyatkin
38 [GO] 2024―Apr―28 Geographical distribution of COVID-19 infection across Saudi Arabia H.M. Aldossari, A. Abdul Salam
39 [GO] 2024―Apr―28 Level of influenza virus strain antibodies in healthy vaccinated people at the end of the COVID-19 pandemic S. V. Iushkova, M. P. Kostinov, L. S. Gladkova, A. A. Kameleva, A. S. Kachnova, A. M. Kostinova, et al. (+6)
40 [GO] 2024―Apr―28 Sustained immunological memory to SARS-CoV-2 antigens. Three years of observation Z. E. Afridonova, A. P. Toptygina, E. L. Semikina
41 [GO] 2024―Apr―28 Investigating SARS-CoV-2 virion material trafficking in syrian hamster neocortecal neurons S. V. Chepur, N. M. Paramonova, I. A. Myasnikova, N. N. Pluzhnikov, M. A. Tyunin, B. A. Kanevsky, N. S. Ilyinsky
42 [GO] 2024―Feb―01 The impact of polymorphic variants of interferon receptor genes on COVID-19 severity and antibiotic resistance E. A. Krieger, O. V. Samodova, O. A. Svitich, R. V. Samoilikov, E. A. Meremianina, L. V. Ivanova, et al. (+7)
43 [GO] 2024―Feb―01 Monitoring of coronavirus infection in the kyrgyz population A. Yu. Popova, V S. Smirnov, O. T. Kasymov, S. S. Egorova, Z. S. Nurmatov, I. V. Drozd, et al. (+13)
44 [GO] 2024―Feb―01 Microbial associations for pneumonia causative agents and level of their resistance to antimicrobial drugs during a new coronavirus infection pandemic O. N. Kolotova, L. V. Kataeva, A. A. Vakarina, T. F. Stepanova, K. B. Stepanova
45 [GO] 2023―Nov―15 EFFECT THE PRE-EXPOSURE PROPHYLACTIC OF HYDROXYCHLOROQUINE ON SEVERE COVID-19 DISEASE: A RANDOMIZED CONTROLLED TRIAL Mahnaz Valizadeh, Termeh Tarjoman, Behnam Farhoudi, Arezoo Chouhdari, Masoumeh Mesgarian, SeyedAhmad SeyedAlinaghi, et al. (+7)
46 [GO] 2023―Nov―15 FROM CORONAVIRUSES TO CORONAVIRUSES Irina V. Kiseleva, Tamila D. Musaeva
47 [GO] 2023―Oct―20 AN UMBRELLA REVIEW ON TREATMENTS AND THERAPEUTIC OPTIONS FOR COVID-19 SeyedAhmad SeyedAlinaghi, Amir Masoud Afsahi, Ayoob Molla, Pegah Mirzapour, Ramin Shahidi, Haleh Siami, et al. (+6)
48 [GO] 2023―Oct―20 The molecular mimicry and COVID-19 Veronika Zorina
49 [GO] 2023―Oct―20 COMORBIDITIES IN COVID-19 AND CT-SEMIOTICS OF INPATIENTS Antonina Viktorovna Titova, Ulyana Konstantinovna Givoyno, Tatiana Petrova Denisova
50 [GO] 2023―Oct―20 ASSESSMENT OF TREC AND KREC LEVELS IN COVID-19 PATIENTS WITH VARYING DISEASE SEVERITY Мария Alexandrovna Saitgalina, Yulia Vladimirovna Ostankova, Natalia Alexandrovna Arsentieva, Zoya Romanovna Korobova, Natalia Evgenievna Liubimova, Victor Anatolievich Kashchenko, et al. (+5)
51 [GO] 2023―Aug―21 PROBIOTICS IN PREVENTION AND TREATMENT OF COVID-19: A SYSTEMATIC REVIEW OF CURRENT EVIDENCE SeyedAhmad SeyedAlinaghi, Ramin Shahidi, Arian Afzalian, Parinaz Paranjkhoo, Kobra Ghorbanzadeh, Hengameh Mojdeganlou, et al. (+10)
52 [GO] 2023―Aug―21 Development of a structure and strain-producer E. coli of an antigen containing sequences of N, S, M, E proteins of the SARS-COV-2 coronavirus Vladimir Vladislavovich Kopat, Anastasia Andreevna Riabchenkova, Elizaveta Romanovna Chirak, Evgenii Leonidovich Chirak, Anna Igorevna Saenko, Nikolai Nikolaevich Kolmakov, et al. (+3)
53 [GO] 2023―Aug―21 Optimization and validation of flow cytometry method for quantification of SARS-COV-2 antigen reactive T-cells Olga M. Strizhakova, Andrey S. Pershin, Alexander A. Kazarov, Ivan V. Lyagoskin, Yana A. Bahareva, Alexander P. Vasil'ev, et al. (+4)
54 [GO] 2023―Aug―21 EVOLUTION OF HERD SARS-COV-2 HUMORAL IMMUNITY IN THE REPUBLIC OF BELARUS Anna Yurievna Popova, Viacheslav Сергеевич Smirnov, Svetlana Alexandrovna Egorova, Alexander Alexandrovich Tarasenko, Alla Mikhailovna Dashkevich, Angelica Marsovna Milichkina, et al. (+18)
55 [GO] 2023―Aug―06 A relation between specific immune status indicators and activity of “lipid peroxidation - antioxidant defense” system in COVID-19 neonates Lyubov V. Rychkova, Marina A. Darenskaya, Alla G. Petrova, Natali V. Semenova, Ekaterina V. Moskaleva, Sergey I. Kolesnikov, et al. (+2)
56 [GO] 2023―Aug―06 Antibiotics hypersensitivity reactions during COVID-19 pandemic Zaruhi G. Kalikyan
57 [GO] 2023―Aug―06 Evaluation of virus-neutralizing antibody level after novel coronavirus infection COVID-19: development of an instant assay assessing protective antibodies using a pseudovirus-based reaction Andrey A. Funtikov, Наталия A. Litvinova, Evgenii V. Zuev, Sergey V. Kulemzin, Rachim R. Shukurov
58 [GO] 2023―Apr―01 Features of lymphocyte subset composition in neonates born to mothers suffered from COVID-19 at different stages of pregnancy Evgeniya V. Inviyaeva, Julia A. Kosolapova, Lyubov V. Krechetova, Valentine V. Vtorushina, Mziya I. Makieva, Victor V. Zubkov
59 [GO] 2023―Apr―01 SARS-CoV-2 collective immunity among the population of the Republic of Armenia Anna Yu. Popova, Vyacheslav S. Smirnov, Svetlana A. Egorova, Artavazd V. Vanyan, Angelika M. Milichkina, Nune G. Bakunts, et al. (+13)
60 [GO] 2023―Apr―01 A clinical case of SARS-CoV-2 infection complicated by nephrogenic pulmonary edema and COVID-associated pneumonitis, alveolitis Olga V. Vorobeva, Natalya E. Gimaldinova, L. P. Romanova
61 [GO] 2023―Mar―20 COLONIZATION AND AZOLE RESISTANCE OF OROPHARYNGEAL CANDIDA FUNGI IN INTENSIVE CARE PATIENTS WITH COVID-19 Svetlana Lisovskaya, Guzel Shavkhatovna Isaeva, Irina Nikolaeva, Sophia Guseva, Lily Gainatullina, Nikita Chumarev
62 [GO] 2023―Mar―16 A CLINICAL CASE OF VIRAL-BACTERIAL PNEUMONIA CAUSED BY SARS-COV-2 AND KLEBSIELLA PNEUMONIAE, COMPLICATED BY A GENERALIZED INFECTION WITH DEVELOPED SEPTICEMIA Lubov Petrovna Romanova, Olga Vasilevna Vorobeva
63 [GO] 2023―Mar―07 Assessment of the formation and intensity of adaptive immunity in patients with COVID-19 Inna Ivanova, Anna Filippenko, Anastasia Trufanova, Natalya Omelchenko, Olga Chemisova, Aleksej Vodopyanov, et al. (+4)
64 [GO] 2023―Mar―07 Clinical case of severe course of Covid-19 in a child with morbid obesity Kirill Vladimirovich Samoylov, Yuliya Alexandrovna Ermolaeva, Daria Alekseevna Ponomareva, Anastasiya Aleksandrovna Khudyakova, Anzhelika Vladimirovna Protsenko
65 [GO] 2023―Mar―07 FOURTH ETHICAL COMMENTS TOWARDS COVID-19 (three year later) - Trust and Faith / social and moral profile of vaccination Olga Kubar, Galina Mikirtichan
66 [GO] 2023―Mar―07 THE ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) IN THE IMMUNOPATHOGENESIS OF SEVERE COVID-19: POTENTIAL IMMUNOTHERAPEUTIC STRATEGIES REGULATING NET FORMATION AND ACTIVITY Irina Vadimovna Nesterova, Margarita Galimovna Atazhakhova, Yuri Valerieviсh Teterin, Valeriya Aleksandrovna Matushkina, Galina Anatolievna Chudilova, Marina Nikolaevna Mitropanova
67 [GO] 2023―Mar―07 INVESTIGATING ANTIGENIC FEATURES OF THE SARS-COV-2 ISOLATED IN RUSSIAN FEDERATION IN 2021-2022 BY HYPERIMMUNE MOUSE SERUM NEUTRALISATION Anna V. Zaykovskaya, Vasily A. Evseenko, Sergey Е. Olkin, Oleg V. Pyankov
68 [GO] 2023―Mar―07 DYNAMICS IN MATURATION OF SARS-COV-2 RBD-SPECIFIC IGG ANTIBODY AVIDITY DEPENDING ON IMMUNIZATION TIMEFRAME AND TYPE Alexandra Mikhailovna Kudryashova, Victor Aleksandrovich Manuylov, Alyona Andreevna Murzina, Alla Nikolaevna Kaira, Olga Vasilievna Borisova
69 [GO] 2023―Mar―07 Maintaining immunological memory to the SARS-CoV-2 virus during a pandemic A. Toptygina, Z. Afridonova, R. Zakirov, E. Semikina
70 [GO] 2022―Nov―24 DYNAMICS OF CLINICAL SYMPTOMS AND SECRETORY IMMUNOGLOBULIN A IN COVID-19 CONVALESCENT PATIENTS Albina А. Khasanova, Mikhail P. Kostinov, Irina L. Soloveva, Tatyana N. Nikitina, Ekaterina A. Khromova
71 [GO] 2022―Nov―24 Predictive value of specific cytokines for lethal COVID-19 outcome N. A. Arsentieva, N. E. Liubimova, O. K. Batsunov, Z. R. Korobova, R. N. Kuznetsova, A. A. Rubinstein, et al. (+10)
72 [GO] 2022―Nov―24 EVALUATION OF THE IMPLEMENTATION OF PREVENTION AND INFECTION CONTROL PROGRAMS IN ARMENIAN HOSPITALS DURING THE COVID-19 PANDEMIC G. Palozyan, Sh. Avetisyan, R. Abovyan, G. Melik-Andreasyan, A. Vanyan
73 [GO] 2022―Nov―24 EPIDEMIOLOGY AND COURSE OF INFECTIOUS DISEASES DURING THE COVID-19 PANDEMIC. REPORT 2: REALIZATION OF INTERFERENCE BETWEEN SARS-COV-2 AND ACUTE RESPIRATORY VIRAL INFECTIONS Nikolay A. Belyakov, Ekaterina V. Boeva, Olga E. Simakina, Daria M. Danilenko, Dmitry A. Lioznov
74 [GO] 2022―Nov―24 Associations between serum levels of C3, C4, and total classical complement activity in COVID-19 patients at the time of admission and clinical outcome A. Razi, A. Azimian, R. Arezumand, A. Solati, H. N. Ahmadabad
75 [GO] 2022―Sep―11 Opportunities for correction of immunosuppression in patients with COVID-19 Mikhail V. Kiselevskiy, H. M. Treshalina, I. N. Mikhailova, D. V. Martirosyan, I. V. Manina, V. V. Reshetnikova, I. G. Kozlov
76 [GO] 2022―Sep―11 A case of abscessed pneumonia due to COVID-19 infection in a young patient Olga V. Vorobeva, L. P. Romanova
77 [GO] 2022―Sep―11 Epidemiology and course of infectious diseases during the COVID-19 pandemic. Report 1. HIV infection, hepatitis c and tuberculosis Nikolay A. Belyakov, Ekaterina V. Boeva, Zinaida M. Zagdyn, Elena V. Esaulenko, Dmitry A. Lioznov, Olga E. Simakina
78 [GO] 2022―Sep―11 Clinical case of rhino-orbital mucormycosis in a convalescent COVID-19 patient: diagnostic and treatment tactics Anna Yu. Popova, Yulia V. Demina, Natalya N. Zaytseva, Natalya S. Kucherenko, Arkadyi N. Denisenko, Anna G. Tochilina, et al. (+5)
79 [GO] 2022―Sep―11 Diagnostics of macrophage activation syndrome, depending on IL-6 initial level in patients with a novel coronavirus infection Svetlana A. Perepelitsa
80 [GO] 2022―Sep―11 Characteristics of respiratory tract bacterial microflora detected in patients suffering from community-acquired pneumonia during continuing spread of the new coronavirus infection in Khabarovsk city (december 2020 - march 2021) Olga E. Trotsenko, Albina P. Bondarenko, Vlada A. Shmylenko, Elena A. Bazykina, Natalia Yu. Pshenichnaya, Tatiana A. Zaitseva, et al. (+2)
81 [GO] 2022―Sep―11 Characterizing A “N-CoV-2-IgG PS” diagnostic kit to quantify SARS-CoV-2 nucleocapsid protein-specific human IgG antibodies Elena V. Zueva, Nikolai N. Belyaev, Vyacheslav N. Verbov, Ivan V. Likhachev, Igor A. Bachinin, Irina V. Khamitova, et al. (+3)
82 [GO] 2022―Sep―11 Intra-laboratory validated “TigraTest® SARS-CoV-2” - test assessing release of interferon gamma in vitro to identify peripheral blood T-lymphocytes specifically responding against SARS-CoV-2 virus antigens Ivan V. Lyagoskin, Pauline E. Kargopolova, Dmitry A. Obyedkov, Irina Yu. Egorova, Rahim R. Shukurov
83 [GO] 2022―Sep―11 Assessing SARS-CoV-2-related mortality rate in Russian regions, based on the econometric model Vladimir S. Stepanov
84 [GO] 2022―Jul―05 The clinical case: COVID-19 in a child with chronic kidney disease Yuliya A. Ermolaeva, Yu. G. Samoilova, O. A. Oleynik, D. A. Kudlay
85 [GO] 2022―May―12 T HELPER CELL SUBSETS AND THEIR TARGET CELLS IN ACUTE COVID-19 I. Kudryavtsev, A. Golovkin, A. Totolian
86 [GO] 2022―May―12 PATHOMORPHOLOGICAL FEATURES OF ARDS IN COMPETING LUNG DISEASES: COVID-19 AND SARCOIDOSIS О. V. Vorobeva, N. E. Gimaldinova, L. P. Romanova
87 [GO] 2022―May―12 Comparison of the humoral and cellular immunity in COVID-19 convalescents Anna P. Toptygina, Elena L. Semikina, Rustam Sh. Zakirov, Zulfiia E. Afridonova
88 [GO] 2022―May―12 FEATURES OF THE NEW CORONAVIRUS INFECTION COVID-19 IN IDENTICAL TWINS S. Yudina, V. Kiseleva, T. Rusanova, I. Ivanova
89 [GO] 2022―May―12 RESISTANCE FACTORS OF KLEBSIELLA PNEUMONIAE BACTERIA DURING COVID-19 PANDEMIC O. N. Kolotova, L. V. Kataeva, I. V. Bakshtanovskaya, K. B. Stepanova, T. F. Stepanova
90 [GO] 2022―May―12 RHINO- AND RS-VIRUSES IN THE COVID-19 PANDEMIC I. V. Kiseleva, A. D. Ksenafontov
91 [GO] 2022―May―12 EVALUATION OF SERUM LEVELS OF IL-6 AND ADIPONECTIN IN COVID-19 PATIENTS AND THEIR RELATIONSHIP WITH DISEASE SEVERITY M. Norouzian, Khojasteh Sharifi-Sarasiabi, Majid Najafi-Asl, M. Hassani Azad, H. Estabraghnia Babaki
92 [GO] 2022―May―12 Local and systemic adverse reactions following COVID-19 vaccine (clinical report) N. Yu. Zherebtsova, T. V. Kajdanek
93 [GO] 2022―May―12 QUANTITATIVE AND QUALITATIVE COMPOSITION OF LYMPHOCYTE POPULATIONS AND SUBSETS IN PATIENTS WITH VARYING SEVERITY OF A NEW CORONAVIRUS INFECTION I. A. Ivanova, A. A. Trufanova, A. V. Filippenko, N. D. Omelchenko, A. K. Noskov, O. S. Chemisova
94 [GO] 2022―May―12 EVALUATION OF THE TWO IN-PATIENT HOSPITALS ON POTENTIAL ENVIRONMENTAL HAZARD DURING THE PERIOD OF NEW CORONAVIRUS INFECTION IN THE KHABAROVSK CITY (DECEMBER 2020 - MARCH 2021) O. E. Trotsenko, A. P. Bondarenko, N. Y. Pshenichnaya, T. A. Zaitseva, Y. A. Garbuz, I. V. Chishagorova, et al. (+3)
95 [GO] 2022―May―12 Anti-interferon alpha autoantibodies and their significance in COVID-19 S. S. Petrikov, N. V. Borovkova, K. A. Popugaev, Mayya V. Storozheva, A. M. Kvasnikov, M. A. Godkov
96 [GO] 2022―May―12 The third ethical commentary to COVID-19 (two years later) - vaccination, solidarity, and trust O. I. Kubar, G. L. Mikirtichan, E. Yu. Vladimirova, T. G. Taghi-zade, F. M. Mamedova, U. K. Gadgieva, et al. (+8)
97 [GO] 2022―Mar―14 Etiological pattern of community-acquired pneumonia related to the new coronavirus infection COVID-19 pandemic in the Saratov Region S. A. Portenko, E. S. Kazakova, E. V. Naidenova, N. A. Osina, M. V. Proskuriakova, A. D. Katyshev, et al. (+11)
98 [GO] 2022―Mar―14 Revealing measles cases in Vietnam during the spread of a new coronavirus infection I. N. Lavrentieva, M. Hoang, A. Y. Antipova, M. A. Bichurina, A. A. Totolyan
99 [GO] 2022―Mar―14 <i>In vitro</i> antiviral activity of VIFERON® rectal suppositories against SARS-CoV-2 I. N. Isakova-Sivak, E. A. Stepanova, L. G. Rudenko, M. S. Bartov, E. N. Vyzhlova, V. V. Malinovskaya
100 [GO] 2021―Dec―15 Differential and diagnostic significance of monocytosis in treatment of moderate forms of COVID-19 M. Shperling, E. Shperling, A. Kovalev, A. Vlasov, A. Polyakov, Ya. Noskov, et al. (+4)
101 [GO] 2021―Dec―15 Gender-Related Response of Body Systems in COVID-19 Affects Outcome M. Khaksari, N. Sabet, Z. Soltani, H. Bashiri
102 [GO] 2021―Dec―15 INFLUENCE OF ULTRAVIOLET BLOOD IRRADIATION ON COVID-19 ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA I. Khodza, P. Puzdryak, P Bondarenko, A. Degtyarev, A. Erofeev, K. Chizhova, et al. (+2)
103 [GO] 2021―Dec―15 SALIENT FEATURES OF CIRCULATING RESPIRATORY VIRUSES IN THE PRE- AND PANDEMIC INFLUENZA AND COVID-19 SEASONS I. V. Kiseleva, N. V. Larionova, E. P. Grigorieva, A. D. Ksenafontov, M. Al Farroukh, L. G. Rudenko
104 [GO] 2021―Dec―15 The correlation between RAS and COVID-19, short review of the latest evidence F. Ferrara, A. Vitiello
105 [GO] 2021―Dec―15 IMMUNOGRAPH-BASED ANALYSIS OF THE INFLUENZA A (H1N1)PDM09 VACCINE STRAIN IMMUNOGENICITY IN THE PANDEMIC AND POST-PANDEMIC PERIOD (2009-2014) V. S. Vakin, I. V. Amosova, E. M. Vojcekhovskaya, T. A. Timoshicheva, A. A. Vasileva, M. G. Pozdnyakova, et al. (+4)
106 [GO] 2021―Nov―22 Study of features of humoral immune response to the new coronavirus infection COVID-19 among healthcare workers I. D. Reshetnikova, Yu. A. Tyurin, E. V. Agafonova, S. N. Kulikov, G. F. Gilyazutdinova, D. V. Lopushov, et al. (+3)
107 [GO] 2021―Nov―22 Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic A. Yu. Popova, A. A. Tarasenko, V. Yu. Smolensky, S. A. Egorova, V. S. Smirnov, A. M. Dashkevich, et al. (+37)
108 [GO] 2021―Sep―21 COVID-19 as a zoonotic infection A. N. Kulichenko, O. V. Maletskaya, N. S. Sarkisyan, A. S. Volynkina
109 [GO] 2021―Sep―21 Methodology for assessing herd immunity to the SARS-CoV-2 virus in the context of the COVID-19 pandemic A. Yu. Popova, A. A. Totolian
110 [GO] 2021―Mar―24 Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation A. Yu. Popova, E. E. Andreeva, E. A. Babura, S. V. Balakhonov, N. S. Bashketova, M. V. Bulanov, et al. (+27)
111 [GO] 2021―Mar―24 A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18-60 years (phase I-II) A. B. Ryzhikov, Е. А. Ryzhikov, M. P. Bogryantseva, S. V. Usova, E. D. Danilenko, E. A. Nechaeva, et al. (+17)
112 [GO] 2021―Mar―02 Second ethical comments towards COVID-19 (one year later) O. I. Kubar, M. A. Bichurina, N. I. Romanenkova
113 [GO] 2020―Sep―28 Parthenolide: suggested drug for COVID-19 M. Nemati, F. Danesh Pouya, E. Roshani Asl, Y. Rami
114 [GO] 2020―Sep―28 THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW OF THE CURRENT EVIDENCE R. Ghomi, N. Asgari, A. Hajiheydari, R. Esteki, F. Biyabanaki, F. Nasirinasab
115 [GO] 2020―Aug―08 Organ-specific pathomorphological changes during COVID-19 O. V. Vorobeva, A. V. Lastochkin
116 [GO] 2020―Aug―08 COVID-19 and BCG vaccine: is there a link? I. V. Lyadova, A. A. Starikov
117 [GO] 2020―Aug―08 Lessons to learn: COVID-19 epidemic in Italy A. V. Semenov, N. Y. Pshenichnaya
118 [GO] 2020―Aug―08 COVID-19: etiology, clinical picture, treatment M. Yu. Shchelkanov, L. V. Kolobukhina, O. A. Burgasova, I. S. Kruzhkova, V. V. Maleev
119 [GO] 2020―Aug―08 Some opportunities for immunotherapy in coronavirus infection V. S. Smirnov, Areg A. Totolian
120 [GO] 2020―May―22 An early assessment of the efficacy of medicines in the treatment of patients with COVID-19 A. S. Kolbin
121 [GO] 2020―May―22 COVID-19: an updated review F. A. Isihak, M. A. Hamad, N. G. Mustafa
122 [GO] 2020―Apr―12 INNATE IMMUNITY IN CORONAVIRUS INFECTION V. Smirnov, A. Totolyan
123 [GO] 2020―Apr―12 THE HISTORY OF INVESTIGATION AND MODERN CLASSIFICATION OF CORONAVIRUSES (NIDOVIRALES: CORONAVIRIDAE) M. Yu. Shchelkanov, A. Yu. Popova, V. G. Dedkov, V. G. Akimkin, V. V. Maleyev
 [1] 

123 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec